Search results for " scales"

showing 10 items of 493 documents

Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S)

2009

To demonstrate the ability of the Screen for Cognitive Impairment in Psychiatry (SCIP-S) to discriminate between cognitively-impaired individuals and those with adequate functioning in a sample of schizophrenic and bipolar patients, as well as in a control group.The SCIP-S, together with a full neuropsychological battery, was administered to three groups: patients with schizophrenia, patients diagnosed with bipolar disorder I, and controls. The battery scores were used to perform a standardization with respect to the control group and this served to determine the comparison groups (cognitively impaired versus unimpaired) for each of the subtests of the SCIP-S. A full analysis of decision va…

AdultMalePsychosismedicine.medical_specialtyBipolar DisorderNeuropsychological TestsSeverity of Illness Indexmental disordersmedicineHumansBipolar disorderPsychiatryBiological PsychiatryCognitive deficitPsychiatric Status Rating ScalesReceiver operating characteristicCognitive disorderCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaSchizophreniaFemalemedicine.symptomCognition DisordersPsychologyNeurocognitiveClinical psychologySchizophrenia Research
researchProduct

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and cha…

1995

Preclinical data indicated that seroquel (ICI 204 636), a dibenzothiazepine with 5-HT2 and D2-like receptor antagonistic properties, might be an effective antipsychotic agent, causing fewer extrapyramidal side effects than typical neuroleptics. In the present study, 12 patients suffering from schizophrenia or schizophreniform disorder with predominantly positive symptomatology were treated in an open clinical trial for 4 weeks with seroquel at a maximum dosage of 750 mg/day. The drug was generally well tolerated, and virtually no adverse extrapyramidal side effects such as acute dystonia, parkinsonism or akathisia were observed. Total scores for BPRS (item score 0–6; baseline: 42.0±2.3; mea…

AdultMalePsychosismedicine.medical_specialtyDibenzothiazepinesTime Factorsmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticThyrotropinAkathisiaGastroenterologyQuetiapine FumarateAntipsychotic AgentInternal medicinemedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesParkinsonismElectroencephalographyMiddle Agedmedicine.diseaseProlactinTreatment OutcomeSchizophreniaAnesthesiaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyAntipsychotic AgentsPsychopharmacology
researchProduct

Differences in cannabis-related experiences between patients with a first episode of psychosis and controls

2016

BackgroundMany studies have reported that cannabis use increases the risk of a first episode of psychosis (FEP). However, only a few studies have investigated the nature of cannabis-related experiences in FEP patients, and none has examined whether these experiences are similar in FEP and general populations. The aim of this study was to explore differences in self-reported cannabis experiences between FEP and non-psychotic populations.MethodA total of 252 subjects, who met International Classification of Diseases (ICD)-10 criteria for FEP, and 217 controls who reported cannabis use were selected from the Genetics and Psychosis (GAP) study. The Medical Research Council Social Schedule and t…

AdultMalePsychosismedicine.medical_specialtyExacerbationPopulationMarijuana SmokingSociodemographic datapsychosiPsychotic Disorder03 medical and health sciencesYoung Adult0302 clinical medicineexperienceSurveys and QuestionnairesmedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansSurveys and QuestionnaireCannabiYoung adulteducationPsychiatrySettore MED/25 - PsichiatriaApplied PsychologyCannabisCannabis; Cannabis Experience Questionnaire; experiences; first episode of psychosis; psychosis; Adult; Cannabis; Female; Humans; Linear Models; Male; Marijuana Smoking; Psychiatric Status Rating Scales; Psychotic Disorders; Surveys and Questionnaires; Young Adult; Applied Psychology; Psychiatry and Mental Healthfirst episode of psychosiFirst episodePsychiatric Status Rating Scaleseducation.field_of_studybiologyCannabis usePsychiatric Status Rating Scalemedicine.diseasebiology.organism_classification030227 psychiatryPsychotic DisordersPsychiatry and Mental HealthCannabis Experience QuestionnaireLinear ModelsLinear ModelFemaleCannabisPsychology030217 neurology & neurosurgeryClinical psychologyHuman
researchProduct

Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes.

2011

Abstract Introduction This study measures the levels of various markers of oxidative stress and inflammation in blood samples from first-episode psychosis (FEP) patients, and examines the association between these peripheral biomarkers and cognitive performance at 6 months after treatment. Methods Twenty-eight FEP patients and 28 healthy controls (matched by age, sex and educational level) had blood samples taken at admission for assessment of total antioxidant status, superoxide dismutase (SOD), total glutathione (GSH), catalase (CAT), glutathione peroxidase, lipid peroxidation, nitrites and the chemokine monocyte chemoattractant protein-1 (MCP-1). A battery of cognitive tests was also app…

AdultMalePsychosismedicine.medical_specialtyNeuropsychological Testsmedicine.disease_causeStatistics NonparametricLipid peroxidationSuperoxide dismutasechemistry.chemical_compoundYoung AdultInternal medicinemedicineHumansBiological PsychiatryChemokine CCL2Nitriteschemistry.chemical_classificationFirst episodePsychiatric Status Rating ScalesGlutathione PeroxidasebiologySuperoxide DismutaseGlutathione peroxidaseCase-control studyGlutathionemedicine.diseaseCatalaseGlutathionePsychiatry and Mental healthOxidative StressEndocrinologychemistryPsychotic DisordersCase-Control StudiesImmunologybiology.proteinLinear ModelsFemaleLipid PeroxidationPsychologyCognition DisordersOxidative stressSchizophrenia research
researchProduct

Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia.

2008

Suicidal attempts are relatively frequent and clinically relevant in patients with schizophrenia. Recent studies have found gray matter differences in suicidal and non-suicidal depressive patients. However, no previous neuroimaging study has investigated possible structural abnormalities associated to suicidal behaviors in patients with schizophrenia. A whole-brain magnetic resonance voxel-based morphometric examination was performed on 37 male patients meeting the DSM-IV criteria for schizophrenia. Thirteen (35.14%) patients had attempted suicide. A non-parametric permutation test was computed to perform the comparability between groups. An analysis of covariance (AnCova) model was constru…

AdultMalePsychosismedicine.medical_specialtyPoison controlFunctional LateralityStatistics NonparametricTemporal lobeSuperior temporal gyrusNeuroimagingmedicineHumansPsychiatryBiological PsychiatryPharmacologyPsychiatric Status Rating ScalesSuicide attemptAge FactorsVoxel-based morphometryMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTemporal LobeFrontal LobeSuicideSchizophreniaOrbitofrontal cortexFemaleSchizophrenic PsychologyPsychologyClinical psychologyProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Detection of Depression in Acute Schizophrenia: Sensitivity and Specificity of 2 Standard Observer Rating Scales

2006

Objective: To compare the psychometric properties of the Calgary Depression Rating Scale (CDRS) and the Hamilton Depression Rating Scale (HDRS) for severity assessment of depression in acute schizophrenia. Method: During clinical routine treatment, we investigated 119 inpatients with acute schizophrenia, using the CDRS, the HDRS, and a global 4-point Depression Severity Scale (DEP-SEV). We compared CDRS and HDRS sum scores regarding their diagnostic accuracy, with global severity of depression as the criterion. We estimated sensitivity and specificity on the basis of receiver operating characteristic curves. Results: According to global clinical ratings (DEP-SEV), 31% of patients had no dep…

AdultMalePsychosismedicine.medical_specialtyPsychometricsAcute schizophreniaStatistics as TopicComorbidityPersonality AssessmentSeverity assessmentRating scaleGermanymedicineHumansPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesDepressive Disorder MajorReproducibility of Resultsmedicine.diseasePsychiatry and Mental healthROC CurveSchizophreniaAcute DiseaseSchizophreniaFemaleStandard observerPsychologyClinical psychologyThe Canadian Journal of Psychiatry
researchProduct

Relationship of Psychiatric Experience and Interrater Reliability in Assessment of Negative Symptoms

1999

AdultMalePsychosismedicine.medical_specialtyPsychometricsPsychometricsmedicineHumansPsychiatryPsychiatric Status Rating ScalesPsychiatryNegative symptomTeachingReproducibility of ResultsVideotape RecordingMiddle Agedmedicine.diseasePsychiatry and Mental healthInter-rater reliabilitySchizophreniaSchizophreniaEducation Medical ContinuingFemaleSchizophrenic PsychologyClinical CompetencePsychologyClinical psychologyThe Journal of Nervous & Mental Disease
researchProduct

Subclinical thought disorder in first-degree relatives of schizophrenic patients. Results from a matched-pairs study with the Thought Disorder Index

1995

To assess the frequency and quality of formal thought disorder in schizophrenic patients and their first-degree relatives, a consecutive series of 36 unmedicated patients, 20 siblings of these patients and 37 normal control subjects were examined with Holzman's Thought Disorder Index (TDI). As a proof of the internal validity of this tool, the patients demonstrated significantly more thought disorder than the controls as measured by the TDI total score and various subscores, which proved the internal validity of this tool in a German-speaking sample. In addition, in a pairwise comparison with controls who were individually matched by age and sex the patients' siblings had a significantly hi…

AdultMalePsychosismedicine.medical_specialtySeverity of Illness IndexThinkingmedicineHumansFamilyInternal validitySiblingFirst-degree relativesPsychiatrySubclinical infectionPsychiatric Status Rating ScalesThought disorderCognitive disorderMiddle Agedmedicine.diseasePsychiatry and Mental healthSchizophreniaSchizophreniaFemalemedicine.symptomPsychologyClinical psychologyActa Psychiatrica Scandinavica
researchProduct

Duration of active psychosis and functional outcomes in first-episode non-affective psychosis.

2018

AbstractBackground:The duration of untreated psychosis (DUP) has been associated with negative outcomes in psychosis; however, few studies have focused on the duration of active psychotic symptoms after commencing treatment (DAT). In this study, we aimed to evaluate the effect of DUP and DAT on functional long-term outcomes (3 years) in patients with early psychosis.Methods:We evaluated the Scale for the Assessment of Positive Symptoms (SAPS) at frequent intervals for 3 years after presentation to determine the DAT for 307 individuals with first-episode psychosis together with DUP and clinical variables. The functional outcomes were assessed using the Disability Assessment Scale (DAS) at th…

AdultMalePsychosismedicine.medical_specialtyTime FactorsLogistic regressionCohort Studies03 medical and health sciencesDisability Evaluation0302 clinical medicineActivities of Daily LivingmedicineHumansProspective StudiesPsychiatryProspective cohort studyFirst episodePsychiatric Status Rating ScalesReceiver operating characteristicbusiness.industrymedicine.disease030227 psychiatryPsychiatry and Mental healthTreatment OutcomePsychotic DisordersSchizophreniaNon affective psychosisdupSchizophreniaFemaleSchizophrenic PsychologybusinessSocial Adjustment030217 neurology & neurosurgeryAntipsychotic AgentsEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Prenatal and postnatal insecticide use and infant neuropsychological development in a multicenter birth cohort study

2013

There is little evidence about exposure to currently used insecticides during early life periods and adverse effects on child neuropsychological development. The aim of this study is to examine the association between residential insecticide use during pregnancy and infancy, and the development of children.Study subjects were participants in the INMA (Environment and Childhood) Project, a Spanish multicenter birth cohort study. Prenatal and postnatal use of indoor insecticides and other variables were obtained from personal interview during pregnancy and infancy. Mental and psychomotor development was assessed around 14 months using the Bayley Scales of Infant Development. The associations …

AdultMaleQuestionnairesPediatricsmedicine.medical_specialtyInsecticides010501 environmental sciencesSocial class01 natural sciencesBayley Scales of Infant DevelopmentCohort Studies03 medical and health sciences0302 clinical medicineChild DevelopmentPregnancyNeurobehavioral manifestationsmedicineHumans030212 general & internal medicineAdverse effectlcsh:Environmental sciences0105 earth and related environmental sciencesGeneral Environmental SciencePsychomotor learninglcsh:GE1-350Reference dosePregnancybusiness.industryMental DisordersNeuropsychologyInfant developmentInfantMercuryPrenatal exposure delayed effectsFetal developmentmedicine.diseaseConfidence interval3. Good healthMaternal ExposureSpainPrenatal Exposure Delayed EffectsLinear ModelsFemalePsychomotor DisordersbusinessEnvironment International
researchProduct